VIVIMEDLAB logo

Vivimed Labs Stock Price

Symbol: NSEI:VIVIMEDLABMarket Cap: ₹410.4mCategory: Pharmaceuticals & Biotech

VIVIMEDLAB Share Price Performance

₹0
0.00 (0.00%)
₹0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

VIVIMEDLAB Community Narratives

There are no narratives available yet.

VIVIMEDLAB Community Fair Values

    Recent VIVIMEDLAB News & Updates

    No updates

    Vivimed Labs Limited Key Details

    ₹1.7b

    Revenue

    ₹2.6b

    Cost of Revenue

    -₹886.4m

    Gross Profit

    ₹2.3b

    Other Expenses

    -₹3.2b

    Earnings

    Last Reported Earnings
    Jun 30, 2023
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -38.82
    Gross Margin
    -51.14%
    Net Profit Margin
    -185.70%
    Debt/Equity Ratio
    960.3%

    Vivimed Labs Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About VIVIMEDLAB

    Founded
    1988
    Employees
    607
    CEO
    Santosh Varalwar
    WebsiteView website
    www.vivimedlabs.com

    Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates in two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers active ingredients primarily for hair dye and photochromic applications. Additionally, the company manufactures Favulous tablets for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

    Indian Market Performance

    • 7 Days: -1.6%
    • 3 Months: 2.7%
    • 1 Year: -6.5%
    • Year to Date: -2.0%
    Over the last 7 days, the market has dropped 1.6%, driven by a decline of 2.1% in the Financials sector. As for last year, the market is also down 6.5%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading